Search results
Results from the WOW.Com Content Network
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman.Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
Joanna Smith-Griffin is the latest Forbes 30 Under 30 alum facing criminal charges, joining Sam Bankman-Fried, Charlie Javice, and Martin Shkreli.
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving ...
Martin Shkreli (2017) Criminal charge: ... Today he is working at a ... Bernie Madoff was an American financier and is known for running the largest Ponzi scheme in history — worth nearly $65 ...
Turing Pharmaceuticals was launched in February 2015 by Martin Shkreli with the acquisition of three major assets from an orphan drug developer called Retrophin: an intranasal formulation of ketamine, an oxytocin nasal solution, and Vecamyl. [7] The company acquired the US marketing rights to Daraprim from Impax Laboratories in August 2015. [8]
Shkreli, who received his “Pharma bro” nickname after his company raised the price of the life-saving drug Daraprim from $13.50 to $750, bought the album for $2m at auction
NEW YORK (Reuters) -Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday ...
On December 9, 2015, Bloomberg Businessweek identified the buyer as hedge fund manager Martin Shkreli. [2] On September 10, 2021 the Wu-Tang Clan broke their own record when the United States Department of Justice, which had seized the album from Martin Shkreli as part of a forfeiture, sold the album for $4,000,000 to crypto collective ...